Mitsuo Terada
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Diagnosis and Treatment
- Cancer Treatment and Pharmacology
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- Cancer Diagnosis and Treatment 2
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Yukío Shimosato (2 shared papers)T Hirota (1 shared paper)Hiroshi Yamamoto (1 shared paper)Shaw Watanabe (1 shared paper)S Hirohashi (1 shared paper)Hitoshi Tsuda (1 shared paper)Shoichiro Tsugane (1 shared paper)Takamasa Yoshida (1 shared paper)
- Journals
- Breast Cancer (7 papers)Japanese Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (4 papers)Cancer Research (2 papers)Scientific Reports (2 papers)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Mitsuo Terada
32 papers receiving 400 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 117
- Oncology 209
- Pathology and Forensic Medicine 42
- Radiology, Nuclear Medicine and Imaging 48
- Immunology and Allergy 12
Countries citing papers authored by Mitsuo Terada
This map shows the geographic impact of Mitsuo Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Terada more than expected).
Fields of papers citing papers by Mitsuo Terada
This network shows the impact of papers produced by Mitsuo Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Terada. The network helps show where Mitsuo Terada may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitsuo Terada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 137 | |
| 2 | 1989 | 71 | |
| 3 | 2018 | 21 | |
| 4 | 2019 | 19 | |
| 5 | 2018 | 15 | |
| 6 | 2021 | 14 | |
| 7 | 2022 | 13 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2019 | 11 | |
| 12 | 2018 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2019 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2018 | 3 |
About Mitsuo Terada
Mitsuo Terada is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 36 papers that have together received 410 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Health Literacy and Information Accessibility (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Diagnosis and Treatment (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cancer Research (117 citations), Oncology (209 citations), Pathology and Forensic Medicine (42 citations), Radiology, Nuclear Medicine and Imaging (48 citations) and Immunology and Allergy (12 citations). Mitsuo Terada has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Yukío Shimosato, T Hirota, Hiroshi Yamamoto, Shaw Watanabe, S Hirohashi, Hitoshi Tsuda, Shoichiro Tsugane, Takamasa Yoshida, Nanae Horisawa and Makiko Mori. Their work appears in journals such as Breast Cancer, Japanese Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.